Similar articles for PMID: 28209908

Year	Number of Results
1964	1
1970	1
1971	1
1974	1
1975	3
1977	3
1978	1
1979	2
1980	1
1982	1
1983	1
1985	1
1987	2
1991	1
1992	1
1994	1
1995	1
1996	1
1997	2
1999	4
2000	2
2002	2
2003	2
2004	1
2005	2
2006	2
2007	6
2008	1
2009	5
2010	3
2011	4
2012	7
2013	1
2014	3
2015	2
2016	1
2017	5
2019	3
2020	2
2024	0

1

Prescribed Activity of ¹³¹I Therapy in Differentiated Thyroid Cancer.

Van Nostrand D. Van Nostrand D. J Nucl Med. 2017 May;58(5):697-699. doi: 10.2967/jnumed.116.188862. Epub 2017 Feb 16. J Nucl Med. 2017. PMID: 28209908 Free article. No abstract available.

2

Sites Performing Dosimetry for Selection of Activity for ¹³¹I Therapy for Differentiated Thyroid Cancer.

Van Nostrand D. Van Nostrand D. J Nucl Med. 2019 Jun;60(6):20N-22N. J Nucl Med. 2019. PMID: 31160436 Free article. No abstract available.

3

Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer.

Padma S, Sundaram PS. Padma S, et al. J Cancer Res Ther. 2016 Jul-Sep;12(3):1109-1113. doi: 10.4103/0973-1482.163677. J Cancer Res Ther. 2016. PMID: 28054519 Free article. Review.

4

Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma.

Verburg FA. Verburg FA. Q J Nucl Med Mol Imaging. 2019 Sep;63(3):253-257. doi: 10.23736/S1824-4785.19.03196-0. Epub 2019 Jul 1. Q J Nucl Med Mol Imaging. 2019. PMID: 31271272 Free article. Review.

5

[Metastasis of differentiated cancers of the thyroid].

Baudin E, Schlumberger M. Baudin E, et al. Ann Endocrinol (Paris). 1997;58(4):326-9. Ann Endocrinol (Paris). 1997. PMID: 9436482 French. No abstract available.

6

Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma.

Van Nostrand D, Atkins F, Moreau S, Aiken M, Kulkarni K, Wu JS, Burman KD, Wartofsky L. Van Nostrand D, et al. Thyroid. 2009 Oct;19(10):1093-8. doi: 10.1089/thy.2008.0339. Thyroid. 2009. PMID: 19732012

7

The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.

McDougall IR. McDougall IR. Thyroid. 2009 Aug;19(8):811-3. doi: 10.1089/thy.2009.1582. Thyroid. 2009. PMID: 19645613 No abstract available.

8

[The external radiotherapy of differentiated thyroid carcinoma].

Sautter-Bihl ML, Heinze HG. Sautter-Bihl ML, et al. Dtsch Med Wochenschr. 1992 Apr 24;117(17):665-8. doi: 10.1055/s-2008-1062362. Dtsch Med Wochenschr. 1992. PMID: 1369745 Review. German. No abstract available.

9

A dosimetric algorithm for patient-specific 131I therapy of thyroid cancer based on a prescribed target-mass reduction.

Traino AC, Di Martino F. Traino AC, et al. Phys Med Biol. 2006 Dec 21;51(24):6449-56. doi: 10.1088/0031-9155/51/24/011. Epub 2006 Nov 30. Phys Med Biol. 2006. PMID: 17148828

10

Radioiodine therapy in patients with stage I differentiated thyroid cancer.

Jonklaas J, Cooper DS, Ain KB, Bigos T, Brierley JD, Haugen BR, Ladenson PW, Magner J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI; National Thyroid Cancer Treatment Cooperative Study Group. Jonklaas J, et al. Thyroid. 2010 Dec;20(12):1423-4. doi: 10.1089/thy.2010.0308. Epub 2010 Nov 7. Thyroid. 2010. PMID: 21054207 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year